A C-reactive protein (CRP) test is a blood test that measures the amount of a protein called C-reactive protein in your blood. C-reactive protein measures general levels of inflammation in your body.
High levels of CRP are caused by infections and many long-term diseases. But a CRP test cannot show where the inflammation is located or what is causing it. Other tests are needed to find the cause and location of the inflammation.
A special type of CRP test, the high-sensitivity CRP test (hs-CRP), may be done to find out if you have an increased chance of having a sudden heart problem, such as a heart attack. Inflammation can damage the inner lining of the arteries and make having a heart attack more likely. But the connection between high CRP levels and heart attack risk is not very well-understood.
High-sensitivity CRP testing is recommended for men over age 50 and women over age 60 who have intermediate risk of having a heart attack in the next 10 years and who have LDL levels less than 3.5 mmol/L.1
A C-reactive protein (CRP) test may also be done to:
There is no special preparation for a C-reactive protein (CRP) test.
Tell your doctor all of the medicines you are taking because some medicines can affect the results.
Talk to your doctor about any concerns you have regarding the need for the test, its risks, how it will be done, or what the results will mean. To help you understand the importance of this test, fill out the medical test information form (What is a PDF document?).
The health professional taking a sample of your blood will:
The blood sample is taken from a vein in your arm. An elastic band is wrapped around your upper arm. It may feel tight. You may feel nothing at all from the needle, or you may feel a quick sting or pinch.
There is very little chance of a problem from having blood sample taken from a vein.
A C-reactive protein (CRP) test is a blood test that measures the amount of a protein called C-reactive protein in your blood.
Normal values may vary from lab to lab. Results are usually available within 24 hours.
The hs-CRP test measures your risk for heart problems. It may be done to find out if you have an increased chance of having a sudden heart problem, such as a heart attack. But the connection between high CRP levels and heart attack risk is not very well-understood.
If you are at intermediate risk for heart attack or stroke and your hs-CRP level is above 2 mg/L, your doctor may recommend steps to help you lower your risk. These recommendations may include lifestyle changes and medicines to help lower risk of heart attack or stroke.
Less than 1.0 mg/L | Lowest risk |
|---|---|
1.0 to 3.0 mg/L | Average risk |
More than 3.0 mg/L | Highest risk |
Many conditions can change CRP levels. Your doctor will talk with you about any abnormal results that may be related to your symptoms and past health.
| Normal: |
|---|
Any condition that results in sudden or severe inflammation may increase your CRP levels.
Some medicines may decrease your CRP levels.
You may not be able to have the test or the results may not be helpful if:
High-sensitivity C-reactive protein (hs-CRP) measures very low amounts of CRP in the blood. This test may help find your risk for heart problems, especially when it is considered along other risk factors such as cholesterol, age, blood pressure, and smoking. But the connection between high CRP levels and heart disease risk is not understood very well.
If you are at intermediate risk for heart attack or stroke and your hs-CRP level is above 2 mg/L, your doctor may recommend steps to help you lower your risk. These recommendations may include lifestyle changes such as quitting smoking, eating right, losing weight, and getting more exercise. Your doctor may also prescribe medicine to help you lower your CRP level and reduce your risk for heart attack or stroke.
| Canadian Cardiovascular Society | |
| 222 Queen Street | |
| Suite 1403 | |
| Ottawa, ON K1P 5V9 | |
| Phone: | 1-877-569-3407 toll-free (613) 569-3407 |
| Fax: | (613) 569-6574 |
| Web Address: | www.ccs.ca |
The Canadian Cardiovascular Society works to advance the cardiovascular health and care of Canadians through leadership, research, and advocacy. | |
| Heart and Stroke Foundation of Canada | |
| 222 Queen Street | |
| Suite 1402 | |
| Ottawa, ON K1P 5V9 | |
| Phone: | (613) 569-4361 |
| Fax: | (613) 569-3278 |
| Web Address: | www.heartandstroke.ca |
The Heart and Stroke Foundation of Canada works to improve the health of Canadians by preventing and reducing disability and death from heart disease and stroke through research, health promotion, and advocacy. | |
| U.S. National Heart, Lung, and Blood Institute (NHLBI) | |
| P.O. Box 30105 | |
| Bethesda, MD 20824-0105 | |
| Phone: | (301) 592-8573 |
| Fax: | (240) 629-3246 |
| TDD: | (240) 629-3255 |
| Email: | nhlbiinfo@nhlbi.nih.gov |
| Web Address: | www.nhlbi.nih.gov |
The U.S. National Heart, Lung, and Blood Institute (NHLBI) information center offers information and publications about preventing and treating:
| |
Citations
- Genest J, et al. (2009). Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Canadian Journal of Cardiology, 25(10): 567–579.
Other Works Consulted
- Buckley DI, et al. (2009). C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 151(7): 483–495.
- Chernecky CC, Berger BJ (2008). Laboratory Tests and Diagnostic Procedures, 5th ed. St. Louis: Saunders.
- Fischbach FT, Dunning MB III, eds. (2009). Manual of Laboratory and Diagnostic Tests, 8th ed. Philadelphia: Lippincott Williams and Wilkins.
- Pagana KD, Pagana TJ (2010). Mosby’s Manual of Diagnostic and Laboratory Tests, 4th ed. St. Louis: Mosby Elsevier.
- Pearson TA, et al. (2003). Markers of inflammation and cardiovascular disease: American Heart Association and the Centers for Disease Control and Prevention scientific statement. Circulation, 107(3): 499–511.
- U.S. Preventive Services Task Force (2009). Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment. Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.uspreventiveservicestaskforce.org/uspstf/uspscoronaryhd.htm.
| By | Healthwise Staff |
|---|---|
| Primary Medical Reviewer | E. Gregory Thompson, MD - Internal Medicine |
| Primary Medical Reviewer | Andrew Swan, MD, CCFP, FCFP - Family Medicine |
| Specialist Medical Reviewer | Stephen Fort, MD, MRCP, FRCPC - Interventional Cardiology |
| Last Revised | May 19, 2010 |
Next Section:
Why It Is DonePrevious Section:
Test OverviewNext Section:
How To PreparePrevious Section:
Why It Is DoneNext Section:
How It Is DonePrevious Section:
How To PrepareNext Section:
How It FeelsPrevious Section:
How It Is DoneNext Section:
RisksPrevious Section:
How It FeelsNext Section:
ResultsPrevious Section:
RisksNext Section:
What Affects the TestPrevious Section:
ResultsNext Section:
What To Think AboutPrevious Section:
What Affects the TestNext Section:
Other Places To Get HelpPrevious Section:
What To Think AboutNext Section:
ReferencesPrevious Section:
Other Places To Get HelpNext Section:
CreditsPrevious Section:
ReferencesLast Revised: May 19, 2010
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.